Pus samples are collected using sterile techniques and cultured to identify the specific microorganisms causing the infection.

Results typically take a few days to allow for culture growth and sensitivity testing. Rapid methods may provide preliminary results sooner.

A positive result indicates the presence of bacteria or fungi in the pus sample, helping to diagnose and treat localized infections effectively.

Yes, the test identifies the specific microorganism causing the infection and determines its susceptibility to antibiotics or antifungal medications.

Minimal risks include slight discomfort during sample collection and rarely, infection at the puncture site. Sterile techniques minimize these risks.

The target INR range for patients on warfarin therapy varies depending on their condition but is typically between 2.0 and 3.0.

Frequency of testing depends on individual patient needs, but initially, it may be done weekly or bi-weekly until stable, then less frequently thereafter.

Yes, the PT / INR Test can help diagnose various clotting disorders, including those related to liver disease or genetic clotting factor deficiencies.

Medications, dietary changes, liver function, and underlying health conditions can all influence PT / INR results.

Yes, the PT / INR Test is a safe and standard diagnostic procedure used worldwide to monitor blood clotting ability and adjust anticoagulant therapy.

Procedures include skin grafting, tissue expansion, scar revision, and flap surgery, depending on the extent and location of the burns.